ETO, a Target of t(8;21) in Acute Leukemia, Interacts with the N-CoR and mSin3 Corepressors

REFERENCES

• Alland, L., R. Muhle, Hou H., Jr., J. Potes, L. Chin, N. Schreiber-Agus, and R. A. DePinho 1997. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression [see comments]. Nature 387: 49–55.
   PubMed Web of Science ®Google Scholar
• Aronson, B. D., A. L. Fisher, K. Blechman, M. Caudy, and J. P. Gergen 1997. Groucho-dependent and -independent repression activities of Runt domain proteins. Mol. Cell. Biol. 17: 5581–5587.
   PubMed Web of Science ®Google Scholar
• Ayer, D., Q. Lawrence, and R. Eisenman 1995. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80: 767–776.
   PubMed Web of Science ®Google Scholar
• Brehm, A., E. A. Miska, D. J. McCance, J. L. Reid, A. J. Bannister, and T. Kouzarides 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391: 597–601.
   PubMed Web of Science ®Google Scholar
• Chen, J. D., and R. M. Evans 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors [see comments]. Nature 377: 454–457.
   PubMed Web of Science ®Google Scholar
• el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817–825.
   PubMed Web of Science ®Google Scholar
• Erickson, P., J. Gao, K. S. Chang, T. Look, E. Whisenant, S. Raimondi, R. Lasher, J. Trujillo, J. Rowley, and H. Drabkin 1992. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 80: 1825–1831.
   PubMed Web of Science ®Google Scholar
• Erickson, P. F., M. Robinson, G. Owens, and H. A. Drabkin 1994. The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor. Cancer Res. 54: 1782–1786.
   PubMed Web of Science ®Google Scholar
• Feinstein, P. G., K. Kornfeld, D. S. Hogness, and R. S. Mann 1995. Identification of homeotic target genes in Drosophila melanogaster including nervy, a proto-oncogene homologue. Genetics 140: 573–586.
   PubMedGoogle Scholar
• Frank, R., J. Zhang, H. Uchida, S. Meyers, S. W. Hiebert, and S. D. Nimer 1995. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene 11: 2667–2674.
   PubMed Web of Science ®Google Scholar
• Grignani, F., S. De Matteis, C. Nervi, L. Tomassoni, V. Gelmetti, M. Cioce, M. Fanelli, M. Ruthardt, F. F. Ferrara, I. Zamir, C. Seiser, F. Grignani, M. A. Lazar, S. Minucci, and P. G. Pelicci 1998. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 391: 815–818.
   PubMed Web of Science ®Google Scholar
• Gross, C. T., and W. McGinnis 1996. DEAF-1, a novel protein that binds an essential region in a Deformed response element. EMBO J. 15: 1961–1970.
   PubMed Web of Science ®Google Scholar
• Grunstein, M. 1997. Histone acetylation in chromatin structure and transcription. Nature 389: 349–352.
   PubMed Web of Science ®Google Scholar
• Hassig, C. A., T. C. Fleischer, A. N. Billin, S. L. Schreiber, and D. E. Ayer 1997. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89: 341–347.
   PubMed Web of Science ®Google Scholar
• He, L. Z., F. Guidez, C. Tribioli, D. Peruzzi, M. Ruthardt, A. Zelent, and P. P. Pandolfi 1998. Distinct interactions of PML-RARalpha and PLZF-RARalpha with corepressors determine differential responses to RA in APL. Nat. Genet. 18: 126–135.
   PubMed Web of Science ®Google Scholar
• Heinzel, T., R. M. Lavinsky, T. M. Mullen, M. Soderstrom, C. D. Laherty, J. Torchia, W. M. Yang, G. Brard, S. D. Ngo, J. R. Davie, E. Seto, R. N. Eisenman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld 1997. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387: 43–48.
   PubMed Web of Science ®Google Scholar
• Horlein, A. J., A. M. Naar, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Soderstrom, C. K. Glass, et al. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor [see comments]. Nature 377: 397–404.
   PubMed Web of Science ®Google Scholar
• Huynh, K., and V. Bardwell. The BCL-6 POZ domain and other POZ domains interact with the co-repressor N-CoR and SMRT. Oncogene, in press.
   Google Scholar
• Kitabayashi, I., K. Ida, F. Morohoshi, A. Yokoyama, N. Mitsuhashi, K. Shimizu, N. Nomura, Y. Hayashi, and M. Ohki 1998. The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1. Mol. Cell. Biol. 18: 846–858.
   PubMedGoogle Scholar
• Kitamura, E., F. Hosoda, K. Shimizu, K. Shinohara, Y. Hayashi, T. Nagase, Y. Yokoyama, and M. Ohki 1998. The partner gene of AML1 in t(16;21) myeloid leukemia is a novel member of the MTG8(ETO) family. Blood 91: 4028–4037.
   PubMedGoogle Scholar
• Klampfer, L., J. Zhang, A. O. Zelenetz, H. Uchida, and S. D. Nimer 1996. The AML1/ETO fusion protein activates transcription of BCL-2. Proc. Natl. Acad. Sci. USA 93: 14059–14064.
   PubMed Web of Science ®Google Scholar
• Kurokawa, R., M. Soderstrom, A. Horlein, S. Halachmi, M. Brown, M. G. Rosenfeld, and C. K. Glass 1995. Polarity-specific activities of retinoic acid receptors determined by a co-repressor [see comments]. Nature 377: 451–454.
   PubMed Web of Science ®Google Scholar
• Laherty, C. D., W.-M. Yang, J.-M. Sun, J. R. Davie, E. Seto, and R. N. Eisenman 1997. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89: 349–356.
   PubMed Web of Science ®Google Scholar
• Lenny, N., S. Meyers, and S. W. Hiebert 1995. Functional domains of the t(8;21) fusion protein, AML-1/ETO. Oncogene 11: 1761–1769.
   PubMedGoogle Scholar
• Lin, R. J., L. Nagy, S. Inoue, W. Shao, Miller W. H., Jr., and R. M. Evans 1998. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391: 811–814.
   PubMed Web of Science ®Google Scholar
• Luo, R. X., A. A. Postigo, and D. C. Dean 1998. Rb interacts with histone deacetylase to repress transcription. Cell 92: 463–473.
   PubMed Web of Science ®Google Scholar
• Lutterbach, B., D. Sun, J. Schuetz, and S. W. Hiebert 1998. The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein. Mol. Cell. Biol. 18: 3604–3611.
   PubMed Web of Science ®Google Scholar
• Lutterbach, B., J. Westendorf, B. Linggi, E. Seto, and S. Hiebert. AML-1, a target of multiple chromosomal translocations in acute leukemia, interacts with mSin3 and represses transcription from the p21Waf1/Cip1 promoter. Submitted for publication.
   Google Scholar
• Magnaghi-Jaulin, L., R. Groisman, I. Naguibneva, P. Robin, S. Lorain, J. P. Le Villain, F. Troalen, D. Trouche, and A. Harel-Bellan 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase [see comments]. Nature 391: 601–605.
   PubMed Web of Science ®Google Scholar
• Meyers, S., J. R. Downing, and S. W. Hiebert 1993. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Mol. Cell. Biol. 13: 6336–6345.
   PubMed Web of Science ®Google Scholar
• Meyers, S., and S. W. Hiebert 1995. Direct and indirect alteration of transcriptional regulation in cancer. Crit. Rev. Eukaryot. Gene Expr. 5: 365–383.
   PubMedGoogle Scholar
• Meyers, S., N. Lenny, and S. W. Hiebert 1995. The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol. Cell. Biol. 15: 1974–1982.
   PubMed Web of Science ®Google Scholar
• Meyers, S., N. Lenny, W. Sun, and S. W. Hiebert 1996. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. Oncogene 13: 303–312.
   PubMed Web of Science ®Google Scholar
• Miyoshi, H., T. Kozu, K. Shimizu, K. Enomoto, N. Maseki, Y. Kaneko, N. Kamada, and M. Ohki 1993. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J. 12: 2715–2721.
   PubMed Web of Science ®Google Scholar
• Nagy, L., H.-Y. Kao, D. Chakravarti, R. J. Lin, C. A. Hassig, D. E. Ayer, S. L. Schreiber, and R. M. Evans 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89: 373–380.
   PubMed Web of Science ®Google Scholar
• Ogawa, E., M. Maruyama, H. Kagoshima, M. Inuzuka, J. Lu, M. Satake, K. Shigesada, and Y. Ito 1993. PEPB2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc. Natl. Acad. Sci. USA 90: 6859–6863.
   PubMed Web of Science ®Google Scholar
• Okuda, T., Z. Cai, S. Yang, N. Lenny, C. Lyu, J. van Deursen, H. Harada, and J. Downing 1998. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. Blood 91: 3134–3143.
   PubMed Web of Science ®Google Scholar
• Pazin, M. J., and J. T. Kadonaga 1997. What’s up and down with histone deacetylation and transcription? Cell 89: 325–328.
   PubMed Web of Science ®Google Scholar
• Rubnitz, J. E., and W. M. Crist 1997. Molecular genetics of childhood cancer: implications for pathogenesis, diagnosis, and treatment. Pediatrics 100: 101–108.
   PubMedGoogle Scholar
• Schreiber-Agus, N., L. Chin, K. Chen, R. Torres, G. Rao, P. Guida, A. I. Skoultchi, and R. A. DePinho 1995. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 80: 777–786.
   PubMed Web of Science ®Google Scholar
• Strom, D., J. Westendorf, B. Lutterbach, J. Nip, J. Downing, H. Harada, N. Lenny, and S. Hiebert. Enforced expression of the AML-1 oncogene shortens the G1 phase of the cell cycle. Submitted for publication.
   Google Scholar
• Taunton, J., C. A. Hassig, and S. L. Schreiber 1996. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p [see comments]. Science 272: 408–411.
   PubMed Web of Science ®Google Scholar
• Uchida, H., J. Zhang, and S. D. Nimer 1997. AML1A and AML1B can transactivate the human IL-3 promoter. J. Immunol. 158: 2251–2258.
   PubMed Web of Science ®Google Scholar
• Westendorf, J. J., C. M. Yamamoto, N. Lenny, J. R. Downing, M. E. Selsted, and S. W. Hiebert 1998. The t(8;21) fusion product, AML-1/ETO, associates with C/EBPα, inhibits C/EBPα-dependent transcription, and blocks granuloctyic differentiation. Mol. Cell. Biol. 18: 322–333.
   PubMed Web of Science ®Google Scholar
• Yergeau, D. A., C. J. Hetherington, Q. Wang, P. Zhang, A. H. Sharpe, M. Binder, M. Marin-Padilla, D. G. Tenen, N. A. Speck, and D. E. Zhang 1997. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat. Genet. 15: 303–306.
   PubMed Web of Science ®Google Scholar
• Zhang, D. E., C. J. Hetherington, S. Meyers, K. L. Rhoades, C. J. Larson, H. M. Chen, S. W. Hiebert, and D. G. Tenen 1996. CCAAT enhancer-binding protein (C/EBP) and AML1 (CBFα2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol. Cell. Biol. 16: 1231–1240.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., R. Iratni, H. Erdjument-Bromage, P. Tempst, and D. Reinberg 1997. Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell 89: 357–364.
   PubMedGoogle Scholar